Search
GlucoTrack Inc
GCTKAdd to Watchlist
0.473USD
-0.307-39.37%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.19MMarket Cap
0.07P/E TTM
More Details of GlucoTrack Inc Company
Glucotrack, Inc. is focused on the design, development, and commercialization of technologies for people with diabetes. The Company is engaged in developing a long-term Implantable Continuous Blood Glucose Monitor (CBGM) for people living with Type 1 diabetes and insulin-dependent Type 2 diabetes. Its CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. Its CBGM technology allows for a less burdensome approach to glucose monitoring. It has also completed four animal studies with evolving prototype systems, all four of which consistently demonstrated a simple implant procedure, functionality, and safety. The Company has also demonstrated continuous glucose sensing in the epidural space via two additional animal trials, both of which demonstrated a simple implant procedure, functionality, and safety.
GlucoTrack Inc Info
Ticker SymbolGCTK
Company nameGlucoTrack Inc
IPO dateApr 09, 2013
CEOGoode (Paul V)
Number of employees11
Security typeOrdinary Share
Fiscal year-endApr 09
Address301 Rt 17 North
CityRUTHERFORD
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code07070
Phone197286757878
Websitehttps://glucotrack.com/
Ticker SymbolGCTK
IPO dateApr 09, 2013
CEOGoode (Paul V)
Company Executives of GlucoTrack Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew K. Balo
Mr. Andrew K. Balo
Independent Director
Independent Director
4.69K
--
Mr. Paul V. Goode, Ph.D.
Mr. Paul V. Goode, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Luis J. Malave
Mr. Luis J. Malave
Independent Director
Independent Director
--
--
Ms. Erin Carter
Ms. Erin Carter
Independent Director
Independent Director
--
--
Mr. Peter C. Wulff
Mr. Peter C. Wulff
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
--
--
Dr. Victoria E. Carr-Brendel, Ph.D.
Dr. Victoria E. Carr-Brendel, Ph.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew K. Balo
Mr. Andrew K. Balo
Independent Director
Independent Director
4.69K
--
Mr. Paul V. Goode, Ph.D.
Mr. Paul V. Goode, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Luis J. Malave
Mr. Luis J. Malave
Independent Director
Independent Director
--
--
Ms. Erin Carter
Ms. Erin Carter
Independent Director
Independent Director
--
--
Mr. Peter C. Wulff
Mr. Peter C. Wulff
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
--
--
Dr. Victoria E. Carr-Brendel, Ph.D.
Dr. Victoria E. Carr-Brendel, Ph.D.
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of GlucoTrack Inc?
The top five shareholders of GlucoTrack Inc are: Mr. Andrew K. Balo
How many institutions hold shares of GlucoTrack Inc (GCTK)?
As of 2026Q1, 28 institutions hold shares of GlucoTrack Inc, with a combined market value of approximately 221.24K, accounting for 11.38% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 100228.00.